Clinical Trial Update: Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)

View source ↗

Summary

Post-marketing safety study of tigecycline (Tygacil) completed; results posted, evaluating safety in patients with complicated skin and skin-structure infection…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intra-abdominal Infections
• Complicated Skin and Skin Structure Infections

Drugs mentioned

• TYGACIL (tigecycline)

Snippet

Sponsor: Pfizer | Conditions: Complicated Skin and Skin Structure Infections, Complicated Intra-abdominal Infections | Status: COMPLETED | Results posted: 2011-07-08